PENTASA

国家: 印度尼西亚

语言: 印度尼西亚文

来源: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

有效成分:

MESALAZINE

可用日期:

ABBOTT INDONESIA - Indonesia

INN（国际名称）:

MESALAZINE

剂量:

1 G

药物剂型:

ENEMA

每包单位数:

DUS, 7 BOTOL PLASTIK @ 100 ML

厂商:

FERRING-LECIVA, A.S - Czech Republic

授权日期:

2020-02-09

产品特点

PROPOSED PACKAGING MATERIAL
Code
PENSUS-I-ID-02.02
Size
NA
Submission
☐
NDA
☐
Renewal
☒
Variation change detail no.: CR 129438, 165591, 148998
Code of previous version
PENSUS-I-ID-01.01
Changes
BPOM Deficiency letter date 19Mar2021 (Revision on contraindication
and interactions)
Reference
☒
CCDS version: CCDS Ver.17 (Jan 2021)
☐
Core PIL version:
☐
SPC country/version/date:
☐
LAC no.:
Name & Date
IRM, 07-Dec-2021
1
PENTASA
®
MESALAZINE
Enema 1g
COMPOSITION
Each enema contains 1 g mesalazine.
Excipients: Disodium edetate, sodium metabisulphite, sodium acetate,
purified water, hydrochloric acid
for pH adjustment.
PHARMACEUTICAL DOSAGE FORM
Enema (rectal suspension)
White to slightly yellow suspension with a pH value between 4.4 and
5.0.
INDICATIONS
Treatment of mild to moderate ulcerative proctosigmoiditis
POSOLOGY AND METHOD OF ADMINISTRATION
_Posology: _
1 enema at bedtime
_ _
_Paediatric population: _
Not recommended
_ _
_Method of administration: _
A visit to the toilet is recommended before administration of enemas.
_Instructions for use: _
Shake the enema container well before use. The enema is protected by
an aluminium foil bag and
should be used immediately after opening of the bag.
The enema may colour the linen and toilet.
CONTRAINDICATIONS
Hypersensitivity to mesalazine, any of the excipients, or salicylates.
Severe liver or renal impairment.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Most patients who are intolerant or hypersensitive to sulphasalazine
are able to take PENTASA
without risk of similar reactions. However, caution is recommended
when treating patients allergic to
sulphasalazine (risk of allergy to salicylates). Severe cutaneous
adverse reactions, including
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN),
have been reported in
association with mesalazine treatment.
In case of acute intolerance reactions such as abdominal cramps, acute
abdominal pain, fever and
severe headache and/or the first appearance of signs and symptoms of
severe skin reactions, such as